Anasetti C

Top coauthors of Anasetti C

Hansen J A (61 papers)

Martin P J (59 papers)

Storb R (57 papers)

Appelbaum F R (56 papers)

Deeg H J (31 papers)

List of Anasetti C publications

2017

Khimani F, Kim J, Chen L, Dean E, Rizk V, et al. 2017. "Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention." Bone marrow transplantation 52 (7) doi:10.1038/bmt.2017.63
Kharfan-Dabaja M A, Parody R, Perkins J, Lopez-Godino O, Lopez-Corral L, et al. 2017. "Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation." Bone marrow transplantation 52 (3) doi:10.1038/bmt.2016.269

2014

Kunter G, Perkins J B, Pidala J, Nishihori T, Kharfan-Dabaja M A, et al. 2014. "Pharmacokinetically-targeted BU and fludarabine as conditioning before allogeneic hematopoietic cell transplantation for adults with ALL in first remission." Bone marrow transplantation 49 (1) doi:10.1038/bmt.2013.121

2013

Nishihori T, Ochoa-Bayona J L, Kim J, Pidala J, Shain K, et al. 2013. "Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma." Bone marrow transplantation doi:10.1038/bmt.2013.37
Pidala J, Kim J, Schell M, Lee S J, Hillgruber R, et al. 2013. "Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization." Bone marrow transplantation 48 (3) doi:10.1038/bmt.2012.150
Pidala J, Craig B M, Lee S J, Majhail N, Quinn G, Anasetti C 2013. "Practice variation in physician referral for allogeneic hematopoietic cell transplantation." Bone marrow transplantation 48 (1) doi:10.1038/bmt.2012.95

2012

Janssen W E, Rahn D, Hackett M, Coyle D, Tomblyn M, et al. 2012. "Apheresis and transplant of hematopoietic progenitor cells (HPC) from allogeneic donors of age above 60 years." Bone marrow transplantation 47 (12) doi:10.1038/bmt.2012.65
Kumar A, Mhaskar A R, Reljic T, Mhaskar R S, Kharfan-Dabaja M A, et al. 2012. "Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review." Leukemia 26 (4) doi:10.1038/leu.2011.349

2011

Perkins J, Field T, Kim J, Kharfan-Dabaja M A, Ayala E, et al. 2011. "Pharmacokinetic targeting of i.v. BU with fludarabine as conditioning before hematopoietic cell transplant: the effect of first-dose area under the concentration time curve on transplant-related outcomes." Bone marrow transplantation 46 (11) doi:10.1038/bmt.2010.315
Pidala J, Kim J, Anasetti C, Kharfan-Dabaja M A, Field T, et al. 2011. "Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity." Bone marrow transplantation 46 (5) doi:10.1038/bmt.2010.190
Uberti J P, Agovi M-A, Tarima S, Haagenson M, Gandham S, et al. 2011. "Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia." Bone marrow transplantation 46 (1) doi:10.1038/bmt.2010.81

2010

Hoda D, Pidala J, Salgado-Vila N, Kim J, Perkins J, et al. 2010. "Sirolimus for treatment of steroid-refractory acute graft-versus-host disease." Bone marrow transplantation 45 (8) doi:10.1038/bmt.2009.343
Pidala J, Kim J, Perkins J, Field T, Fernandez H, et al. 2010. "Mycophenolate mofetil for the management of steroid-refractory acute graft vs host disease." Bone marrow transplantation 45 (5) doi:10.1038/bmt.2009.252
Gergis U, Markey K, Greene J, Kharfan-Dabaja M, Field T, et al. 2010. "Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD." Bone marrow transplantation 45 (4) doi:10.1038/bmt.2009.210
Field T, Perkins J, Huang Y, Kharfan-Dabaja M A, Alsina M, et al. 2010. "5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation." Bone marrow transplantation 45 (2) doi:10.1038/bmt.2009.134

2007

Kharfan-Dabaja M A, Ayala E, Greene J, Rojiani A, Murtagh F R, Anasetti C 2007. "Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature." Bone marrow transplantation 39 (2) doi:10.1038/sj.bmt.1705548

2004

Yusuf U, Frangoul H A, Gooley T A, Woolfrey A E, Carpenter P A, et al. 2004. "Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience." Bone marrow transplantation 33 (8) doi:10.1038/sj.bmt.1704438

2003

Chen Chien-Shing, Boeckh M, Seidel K, Clark J G, Kansu E, et al. 2003. "Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation." Bone marrow transplantation 32 (5) doi:10.1038/sj.bmt.1704162
Petersdorf E W, Anasetti C, Martin P J, Hansen J A 2003. "Tissue typing in support of unrelated hematopoietic cell transplantation." Tissue antigens 61 (1) doi:

2002

McCune J S, Gooley T, Gibbs J P, Sanders J E, Petersdorf E W, et al. 2002. "Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation." Bone marrow transplantation 30 (3) doi:10.1038/sj.bmt.1703612
Remberger M, Storer B, Ringdén O, Anasetti C 2002. "Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors." Bone marrow transplantation 29 (5) doi:10.1038/sj.bmt.1703374

2001

Benito A I, Furlong T, Martin P J, Anasetti C, Appelbaum F R, et al. 2001. "Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease." Transplantation 72 (12) doi:
Petersdorf E W, Hansen J A, Martin P J, Woolfrey A, Malkki M, et al. 2001. "Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation." The New England journal of medicine 345 (25) doi:10.1056/NEJMoa011826
Kansu E, Gooley T, Flowers M E, Anasetti C, Deeg H J, et al. 2001. "Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial." Blood 98 (13) doi:
Lee S J, Klein J P, Anasetti C, Antin J H, Loberiza F R, et al. 2001. "The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase." Blood 98 (12) doi:
Anasetti C, Petersdorf E W, Martin P J, Woolfrey A, Hansen J A 2001. "Trends in transplantation of hematopoietic stem cells from unrelated donors." Current opinion in hematology 8 (6) doi:
Kollman C, Howe C W, Anasetti C, Antin J H, Davies S M, et al. 2001. "Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age." Blood 98 (7) doi:
Petersdorf E, Anasetti C, Martin P J, Woolfrey A, Smith A, et al. 2001. "Genomics of unrelated-donor hematopoietic cell transplantation." Current opinion in immunology 13 (5) doi:
Zerr D M, Gooley T A, Yeung L, Huang M L, Carpenter P, et al. 2001. "Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 33 (6) doi:10.1086/322642
Ohishi K, Varnum-Finney B, Serda R E, Anasetti C, Bernstein I D 2001. "The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells." Blood 98 (5) doi:
Yu X, Carpenter P, Anasetti C 2001. "Advances in transplantation tolerance." Lancet 357 (9272) doi:
Yu X Z, Bidwell S J, Martin P J, Anasetti C 2001. "Anti-CD3 epsilon F(ab')2 prevents graft-versus-host disease by selectively depleting donor T cells activated by recipient alloantigens." Journal of immunology (Baltimore, Md. : 1950) 166 (9) doi:
Witherspoon R P, Deeg H J, Storer B, Anasetti C, Storb R, Appelbaum F R 2001. "Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19 (8) doi:
Cornelissen J J, Carston M, Kollman C, King R, Dekker A W, et al. 2001. "Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome." Blood 97 (6) doi:
Petersdorf E W, Gooley T, Malkki M, Anasetti C, Martin P, et al. 2001. "The biological significance of HLA-DP gene variation in haematopoietic cell transplantation." British journal of haematology 112 (4) doi:
Jurado M, Deeg H, Gooley T, Anasetti C, Chauncey T, et al. 2001. "Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia." British journal of haematology 112 (2) doi:
Pei J, Akatsuka Y, Anasetti C, Lin M T, Petersdorf E W, et al. 2001. "Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 7 (7) doi:
Deeg H J, Amylon I D, Harris R E, Collins R, Beatty P G, et al. 2001. "Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 7 (4) doi:

2000

Davies S M, Kollman C, Anasetti C, Antin J H, Gajewski J, et al. 2000. "Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program." Blood 96 (13) doi:
Koc S, Leisenring W, Flowers M E, Anasetti C, Deeg H J, et al. 2000. "Thalidomide for treatment of patients with chronic graft-versus-host disease." Blood 96 (12) doi:
Carpenter P A, Pavlovic S, Tso J Y, Press O W, Gooley T, et al. 2000. "Non-Fc receptor-binding humanized anti-CD3 antibodies induce apoptosis of activated human T cells." Journal of immunology (Baltimore, Md. : 1950) 165 (11) doi:
Furlong T, Storb R, Anasetti C, Appelbaum F R, Deeg H J, et al. 2000. "Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities." Bone marrow transplantation 26 (9) doi:10.1038/sj.bmt.1702639
Nash R A, Antin J H, Karanes C, Fay J W, Avalos B R, et al. 2000. "Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors." Blood 96 (6) doi:
Sierra J, Storer B, Hansen J A, Martin P J, Petersdorf E W, et al. 2000. "Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience." Bone marrow transplantation 26 (4) doi:10.1038/sj.bmt.1702519
Zang D Y, Deeg H J, Gooley T, Anderson J E, Anasetti C, et al. 2000. "Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation." British journal of haematology 110 (1) doi:
Ohishi K, Varnum-Finney B, Flowers D, Anasetti C, Myerson D, Bernstein I D 2000. "Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1." Blood 95 (9) doi:
Yu X Z, Bidwell S J, Martin P J, Anasetti C 2000. "CD28-specific antibody prevents graft-versus-host disease in mice." Journal of immunology (Baltimore, Md. : 1950) 164 (9) doi:
Arpinati M, Green C L, Heimfeld S, Heuser J E, Anasetti C 2000. "Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells." Blood 95 (8) doi:
McGlave P B, Shu X O, Wen W, Anasetti C, Nademanee A, et al. 2000. "Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program." Blood 95 (7) doi:
Anasetti C, Petersdorf E W, Martin P J, Woolfrey A, Hansen J A 2000. "Improving availability and safety of unrelated donor transplants." Current opinion in oncology 12 (2) doi:
Anasetti C 2000. "Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia." Leukemia 14 (3) doi:
Deeg H J, Shulman H M, Anderson J E, Bryant E M, Gooley T A, et al. 2000. "Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age." Blood 95 (4) doi:
Mickelson E M, Petersdorf E, Anasetti C, Martin P, Woolfrey A, Hansen J A 2000. "HLA matching in hematopoietic cell transplantation." Human immunology 61 (2) doi:
Yu X Z, Anasetti C 2000. "Enhancement of susceptibility to Fas-mediated apoptosis of TH1 cells by nonmitogenic anti-CD3epsilon F(ab')2." Transplantation 69 (1) doi:
Carnevale-Schianca F, Martin P, Sullivan K, Flowers M, Gooley T, et al. 2000. "Changing from cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 6 (6) doi:
Radich J P, Gooley T, Sanders J E, Anasetti C, Chauncey T, Appelbaum F R 2000. "Second allogeneic transplantation after failure of first autologous transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 6 (3) doi:
Flowers M E, Leisenring W, Beach K, Riddell S, Radich J P, et al. 2000. "Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 6 (3A) doi:

1999

Matsumoto K, Anasetti C 1999. "The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia." Leukemia & lymphoma 35 (5-6) doi:10.1080/10428199909169607
Yu X Z, Bidwell S, Martin P J, Anasetti C 1999. "Visualization, fate, and pathogenicity of antigen-specific CD8+ T cells in the graft-versus-host reaction." Journal of immunology (Baltimore, Md. : 1950) 163 (9) doi:
Petersdorf E W, Mickelson E M, Anasetti C, Martin P J, Woolfrey A E, Hansen J A 1999. "Effect of HLA mismatches on the outcome of hematopoietic transplants." Current opinion in immunology 11 (5) doi:
Martin P J, Rowley S D, Anasetti C, Chauncey T R, Gooley T, et al. 1999. "A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients." Blood 94 (7) doi:
Cole M S, Stellrecht K E, Shi J D, Homola M, Hsu D H, et al. 1999. "HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro." Transplantation 68 (4) doi:
Zhu L, Yu X, Akatsuka Y, Cooper J A, Anasetti C 1999. "Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells." Immunology 97 (1) doi:
Deeg H J, Seidel K, Casper J, Anasetti C, Davies S, et al. 1999. "Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 5 (4) doi:
Feinstein L C, Seidel K, Jocum J, Bowden R A, Anasetti C, et al. 1999. "Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 5 (6) doi:
Woolfrey A, Anasetti C 1999. "Allogeneic hematopoietic stem-cell engraftment and graft failure." Pediatric transplantation 3 Suppl 1 doi:

1998

Lee S J, Anasetti C, Kuntz K M, Patten J, Antin J H, Weeks J C 1998. "The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia." Blood 92 (11) doi:
Petersdorf E W, Gooley T A, Anasetti C, Martin P J, Smith A G, et al. 1998. "Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient." Blood 92 (10) doi:
Woolfrey A E, Gooley T A, Sievers E L, Milner L A, Andrews R G, et al. 1998. "Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome." Blood 92 (10) doi:
Stucki A, Leisenring W, Sandmaier B M, Sanders J, Anasetti C, Storb R 1998. "Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis)." Blood 92 (8) doi:
Yu X Z, Martin P J, Anasetti C 1998. "Role of CD28 in acute graft-versus-host disease." Blood 92 (8) doi:
Rondelli D, Raspadori D, Anasetti C, Bandini G, Re F, et al. 1998. "Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells." Bone marrow transplantation 22 (7) doi:10.1038/sj.bmt.1701413
Lee S J, Anasetti C, Horowitz M M, Antin J H 1998. "Initial therapy for chronic myelogenous leukemia: playing the odds." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 16 (9) doi:
Ren S, Kalhorn T F, McDonald G B, Anasetti C, Appelbaum F R, Slattery J T 1998. "Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients." Clinical pharmacology and therapeutics 64 (3) doi:10.1016/S0009-9236(98)90178-3
Morton A J, Gooley T, Hansen J A, Appelbaum F R, Bruemmer B, et al. 1998. "Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase." Blood 92 (2) doi:
Sullivan K M, Anasetti C, Horowitz M, Rowlings P A, Petersdorf E W, et al. 1998. "Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry." Annals of the New York Academy of Sciences 850 doi:
Rondelli D, Anasetti C, Fortuna A, Ratta M, Arpinati M, et al. 1998. "T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells." Bone marrow transplantation 21 (12) doi:10.1038/sj.bmt.1701259
Ryncarz R E, Anasetti C 1998. "Expression of CD86 on human marrow CD34(+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells." Blood 91 (10) doi:
Hansen J A, Gooley T A, Martin P J, Appelbaum F, Chauncey T R, et al. 1998. "Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia." The New England journal of medicine 338 (14) doi:10.1056/NEJM199804023381405
Petersdorf E, Anasetti C, Servida P, Martin P, Hansen J 1998. "Effect of HLA matching on outcome of related and unrelated donor transplantation therapy for chronic myelogenous leukemia." Hematology/oncology clinics of North America 12 (1) doi:
Martin P, Nash R, Sanders J, Leisenring W, Anasetti C, et al. 1998. "Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation." Bone marrow transplantation 21 (3) doi:10.1038/sj.bmt.1701083
Martin P J, Gooley T, Anasetti C, Petersdorf E W, Hansen J A 1998. "HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 4 (3) doi:10.1053/bbmt.1998.v4.pm9923410

1997

Cole M S, Anasetti C, Tso J Y 1997. "Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells." Journal of immunology (Baltimore, Md. : 1950) 159 (7) doi:
Storb R, Leisenring W, Anasetti C, Appelbaum F R, Deeg H J, et al. 1997. "Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?" Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 3 (4) doi:
Sierra J, Radich J, Hansen J A, Martin P J, Petersdorf E W, et al. 1997. "Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia." Blood 90 (4) doi:
Martin P J, Petersdorf E W, Anasetti C, Hansen J A 1997. "HLA homozygosity and the risk of graft-versus-host disease." Tissue antigens 50 (2) doi:
Pei J, Martin P J, Longton G, Masewicz S, Mickelson E, et al. 1997. "Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 3 (3) doi:
Hansen J A, Petersdorf E, Martin P J, Anasetti C 1997. "Hematopoietic stem cell transplants from unrelated donors." Immunological reviews 157 doi:
Sierra J, Storer B, Hansen J A, Bjerke J W, Martin P J, et al. 1997. "Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose." Blood 89 (11) doi:
Clift R A, Anasetti C 1997. "Allografting for chronic myeloid leukaemia." Baillière's clinical haematology 10 (2) doi:
Deeg H J, Lin D, Leisenring W, Boeckh M, Anasetti C, et al. 1997. "Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial." Blood 89 (10) doi:
Slattery J T, Clift R A, Buckner C D, Radich J, Storer B, et al. 1997. "Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation." Blood 89 (8) doi:
Anderson J E, Gooley T A, Schoch G, Anasetti C, Bensinger W I, et al. 1997. "Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy." Blood 89 (7) doi:
Petersdorf E W, Longton G M, Anasetti C, Mickelson E M, McKinney S K, et al. 1997. "Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors." Blood 89 (5) doi:

1996

Petersdorf E W, Longton G M, Anasetti C, Mickelson E M, Smith A G, et al. 1996. "Definition of HLA-DQ as a transplantation antigen." Proceedings of the National Academy of Sciences of the United States of America 93 (26) doi:
Nash R A, Piñeiro L A, Storb R, Deeg H J, Fitzsimmons W E, et al. 1996. "FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors." Blood 88 (9) doi:
Yu X Z, Zhu L, Davis J E, Tso J Y, Hansen J A, Anasetti C 1996. "Induction of apoptosis by anti-CD3 epsilon F(ab')2 in antigen receptor transgenic murine T cells activated by specific peptide." Journal of immunology (Baltimore, Md. : 1950) 157 (8) doi:
Rondelli D, Andrews R G, Hansen J A, Ryncarz R, Faerber M A, Anasetti C 1996. "Alloantigen presenting function of normal human CD34+ hematopoietic cells." Blood 88 (7) doi:
Bensinger W I, Buckner C D, Anasetti C, Clift R, Storb R, et al. 1996. "Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome." Blood 88 (7) doi:
McCarthy P L, Williams L, Harris-Bacile M, Yen J, Przepiorka D, et al. 1996. "A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease." Transplantation 62 (5) doi:
Martin P J, Nelson B J, Appelbaum F R, Anasetti C, Deeg H J, et al. 1996. "Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation." Blood 88 (3) doi:
Slattery J T, Kalhorn T F, McDonald G B, Lambert K, Buckner C D, et al. 1996. "Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 14 (5) doi:
Anderson J E, Anasetti C, Appelbaum F R, Schoch G, Gooley T A, et al. 1996. "Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia." British journal of haematology 93 (1) doi:
Langston A A, Sanders J E, Deeg H J, Crawford S W, Anasetti C, et al. 1996. "Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita." British journal of haematology 92 (3) doi:
Sullivan K M, Storek J, Kopecky K J, Jocom J, Longton G, et al. 1996. "A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2 (1) doi:
Wagner J L, Deeg H J, Seidel K, Anasetti C, Doney K, et al. 1996. "Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience." Transplantation 61 (1) doi:
Anderson J E, Appelbaum F R, Schoch G, Gooley T, Anasetti C, et al. 1996. "Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 14 (1) doi:
Anderson J E, Appelbaum F R, Schoch G, Gooley T, Anasetti C, et al. 1996. "Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors." Blood 87 (1) doi:
Bensinger W I, Clift R A, Anasetti C, Appelbaum F A, Demirer T, et al. 1996. "Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor." Stem cells (Dayton, Ohio) 14 (1) doi:10.1002/stem.140090
Mickelson E M, Longton G, Anasetti C, Petersdorf E, Martin P, et al. 1996. "Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation." Tissue antigens 47 (1) doi:

1995

Sierra J, Anasetti C 1995. "Marrow transplantation from unrelated donors." Current opinion in hematology 2 (6) doi:
Balduzzi A, Gooley T, Anasetti C, Sanders J E, Martin P J, et al. 1995. "Unrelated donor marrow transplantation in children." Blood 86 (8) doi:
Petersdorf E W, Longton G M, Anasetti C, Martin P J, Mickelson E M, et al. 1995. "The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation." Blood 86 (4) doi:
Appelbaum F R, Clift R, Radich J, Anasetti C, Buckner C D 1995. "Bone marrow transplantation for chronic myelogenous leukemia." Seminars in oncology 22 (4) doi:
Doney K C, Storb R, Beach K, Anasetti C, Deeg H J, et al. 1995. "A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants." Transplantation 60 (1) doi:
Slattery J T, Sanders J E, Buckner C D, Schaffer R L, Lambert K W, et al. 1995. "Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics." Bone marrow transplantation 16 (1) doi:
Nash R A, Etzioni R, Storb R, Furlong T, Gooley T, et al. 1995. "Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study." Blood 85 (12) doi:
Demirer T, Weaver C H, Buckner C D, Petersen F B, Bensinger W I, et al. 1995. "High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 13 (3) doi:
Anasetti C, Etzioni R, Petersdorf E W, Martin P J, Hansen J A 1995. "Marrow transplantation from unrelated volunteer donors." Annual review of medicine 46 doi:10.1146/annurev.med.46.1.169
Zhu L, Anasetti C 1995. "Cell cycle control of apoptosis in human leukemic T cells." Journal of immunology (Baltimore, Md. : 1950) 154 (1) doi:
Hansen J A, Mickelson E, Petersdorf E W, Anderson J, Sierra J, et al. 1995. "Marrow transplants from unrelated donors." Clinical transplants doi:

1994

Clift R A, Buckner C D, Thomas E D, Bryant E, Anasetti C, et al. 1994. "Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia." Blood 84 (12) doi:
Anasetti C, Hansen J A 1994. "Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors." Transfusion science 15 (3) doi:10.1016/0955-3886(94)90134-1
Anasetti C, Hansen J A, Waldmann T A, Appelbaum F R, Davis J, et al. 1994. "Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor." Blood 84 (4) doi:
Mickelson E M, Guthrie L A, Etzioni R, Anasetti C, Martin P J, Hansen J A 1994. "Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors." Tissue antigens 44 (2) doi:
Storb R, Etzioni R, Anasetti C, Appelbaum F R, Buckner C D, et al. 1994. "Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia." Blood 84 (3) doi:
Anasetti C, Howe C, Petersdorf E W, Martin P J, Hansen J A 1994. "Marrow transplants from HLA matched unrelated donors: an NMDP update and the Seattle experience." Bone marrow transplantation 13 (6) doi:
Hansen J A, Anasetti C, Petersdorf E, Clift R A, Martin P J 1994. "Marrow transplants from unrelated donors." Transplantation proceedings 26 (3) doi:
Busca A, Anasetti C, Anderson G, Appelbaum F R, Buckner C D, et al. 1994. "Unrelated donor or autologous marrow transplantation for treatment of acute leukemia." Blood 83 (10) doi:
Sanders J E, Storb R, Anasetti C, Deeg H J, Doney K, et al. 1994. "Marrow transplant experience for children with severe aplastic anemia." The American journal of pediatric hematology/oncology 16 (1) doi:
Bearman S I, Mori M, Beatty P G, Meyer W G, Buckner C D, et al. 1994. "Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors." Bone marrow transplantation 13 (1) doi:

1993

Doney K, Buckner C D, Fisher L, Petersen F B, Sanders J, et al. 1993. "Autologous bone marrow transplantation for acute lymphoblastic leukemia." Bone marrow transplantation 12 (4) doi:
Anderson J E, Appelbaum F R, Fisher L D, Schoch G, Shulman H, et al. 1993. "Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome." Blood 82 (2) doi:
Weaver C H, Appelbaum F R, Petersen F B, Clift R, Singer J, et al. 1993. "High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy." Journal of clinical oncology : official journal of the American Society of Clinical Oncology 11 (7) doi:
Voltarelli J C, Gjerset G, Anasetti C 1993. "Adhesion of CD16+ K cells to antibody-coated targets is mediated by CD2 and CD18 receptors." Immunology 79 (3) doi:
Nemunaitis J, Anasetti C, Bianco J A, Hasen J, Singer J W 1993. "rhGM-CSF after allogeneic bone marrow transplantation from unrelated donors: a pilot study of cyclosporine and prednisone as graft-versus-host disease prophylaxis." Leukemia & lymphoma 10 (3) doi:10.3109/10428199309145880
Petersdorf E W, Smith A G, Mickelson E M, Longton G M, Anasetti C, et al. 1993. "The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation." Blood 81 (7) doi:
McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, et al. 1993. "Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program." Blood 81 (2) doi:
Tan P, Anasetti C, Hansen J A, Melrose J, Brunvand M, et al. 1993. "Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1." The Journal of experimental medicine 177 (1) doi:
Hansen J A, Anasetti C, Martin P J, Mickelson E M, Petersdorf E, Thomas E D 1993. "Allogeneic marrow transplantation: the Seattle experience." Clinical transplants doi:
Choo S Y, Starling G C, Anasetti C, Hansen J A 1993. "Selection of an unrelated donor for marrow transplantation facilitated by the molecular characterization of a novel HLA-A allele." Human immunology 36 (1) doi:
Beatty P G, Anasetti C, Hansen J A, Longton G M, Sanders J E, et al. 1993. "Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus." Blood 81 (1) doi:

1992

Linsley P S, Greene J L, Tan P, Bradshaw J, Ledbetter J A, et al. 1992. "Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes." The Journal of experimental medicine 176 (6) doi:
Anasetti C, Martin P J, Storb R, Appelbaum F R, Beatty P G, et al. 1992. "Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody." Transplantation 54 (5) doi:
Anasetti C, Hansen J A 1992. "Marrow transplantation in cancer therapy." The Tohoku journal of experimental medicine 168 (2) doi:
Nash R A, Pepe M S, Storb R, Longton G, Pettinger M, et al. 1992. "Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate." Blood 80 (7) doi:
Doney K, Pepe M, Storb R, Bryant E, Anasetti C, et al. 1992. "Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone." Blood 79 (10) doi:
Nemunaitis J, Anasetti C, Storb R, Bianco J A, Buckner C D, et al. 1992. "Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors." Blood 79 (10) doi:
Stockschlaeder M, Storb R, Pepe M, Longton G, McDonald G, et al. 1992. "A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation." British journal of haematology 80 (1) doi:
Hows J, Szydlo R, Anasetti C, Camitta B, Gajewski J, Gluckman E 1992. "Unrelated donor marrow transplants for severe acquired aplastic anemia." Bone marrow transplantation 10 Suppl 1 doi:

1991

Doney K, Fisher L D, Appelbaum F R, Buckner C D, Storb R, et al. 1991. "Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival." Bone marrow transplantation 7 (6) doi:
Anasetti C, Martin P J, Storb R, Appelbaum F R, Beatty P G, et al. 1991. "Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3." Bone marrow transplantation 7 (5) doi:
Clift R A, Buckner C D, Appelbaum F R, Bryant E, Bearman S I, et al. 1991. "Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens." Blood 77 (8) doi:
Anasetti C 1991. "The role of the immunogenetics laboratory in marrow transplantation." Archives of pathology & laboratory medicine 115 (3) doi:
Beatty P G, Hansen J A, Longton G M, Thomas E D, Sanders J E, et al. 1991. "Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies." Transplantation 51 (2) doi:
Buckner C D, Anasetti C, Bianco J, Nemunaitis J 1991. "Allogeneic bone marrow transplantation for patients with hematologic malignancies." Schweizerische medizinische Wochenschrift. Supplementum 43 doi:

1990

Anasetti C, Tan P, Hansen J A, Martin P J 1990. "Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen." The Journal of experimental medicine 172 (6) doi:
Clift R A, Buckner C D, Appelbaum F R, Bearman S I, Petersen F B, et al. 1990. "Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens." Blood 76 (9) doi:
Martin P J, Schoch G, Fisher L, Byers V, Anasetti C, et al. 1990. "A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment." Blood 76 (8) doi:
Anasetti C, Beatty P G, Storb R, Martin P J, Mori M, et al. 1990. "Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma." Human immunology 29 (2) doi:
Storb R, Pepe M, Anasetti C, Appelbaum F R, Beatty P, et al. 1990. "What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?" Blood 76 (5) doi:
Tan P, Anasetti C, Martin P J, Hansen J A 1990. "Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor." Journal of immunology (Baltimore, Md. : 1950) 145 (2) doi:
Anasetti C, Martin P J, Hansen J A, Appelbaum F R, Beatty P G, et al. 1990. "A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease." Transplantation 50 (1) doi:
Beatty P G, Anasetti C 1990. "Marrow transplantation from donors other than HLA identical siblings." Hematology/oncology clinics of North America 4 (3) doi:
Appelbaum F R, Barrall J, Storb R, Fisher L D, Schoch G, et al. 1990. "Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome." Annals of internal medicine 112 (8) doi:
Schmid I, Anasetti C, Petersen F B, Storb R 1990. "Marrow transplantation for severe aplastic anemia associated with exposure to quinacrine." Blut 61 (2-3) doi:

1989

Sanders J, Sullivan K, Witherspoon R, Doney K, Anasetti C, et al. 1989. "Long term effects and quality of life in children and adults after marrow transplantation." Bone marrow transplantation 4 Suppl 4 doi:
Sullivan K M, Weiden P L, Storb R, Witherspoon R P, Fefer A, et al. 1989. "Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia." Blood 73 (6) doi:
Storb R, Deeg H J, Pepe M, Appelbaum F, Anasetti C, et al. 1989. "Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial." Blood 73 (6) doi:
Anasetti C, Rybka W, Sullivan K M, Banaji M, Slichter S J 1989. "Graft-v-host disease is associated with autoimmune-like thrombocytopenia." Blood 73 (4) doi:
Anasetti C, Amos D, Beatty P G, Appelbaum F R, Bensinger W, et al. 1989. "Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma." The New England journal of medicine 320 (4) doi:10.1056/NEJM198901263200401
Hansen J A, Anasetti C, Beatty P G, Martin P J, Thomas E D 1989. "Allogeneic marrow transplantation: the Seattle experience." Clinical transplants doi:

1988

Sullivan K M, Witherspoon R P, Storb R, Deeg H J, Dahlberg S, et al. 1988. "Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease." Blood 72 (2) doi:
Martin P J, Hansen J A, Anasetti C, Zutter M, Durnam D, et al. 1988. "Treatment of acute graft-versus-host disease with anti-CD3 monoclonal antibodies." American journal of kidney diseases : the official journal of the National Kidney Foundation 11 (2) doi:

1987

Anasetti C, Martin P J, June C H, Hellstrom K E, Ledbetter J A, et al. 1987. "Induction of calcium flux and enhancement of cytolytic activity in natural killer cells by cross-linking of the sheep erythrocyte binding protein (CD2) and the Fc-receptor (CD16)." Journal of immunology (Baltimore, Md. : 1950) 139 (6) doi:
Anasetti C, Martin P J, Morishita Y, Badger C C, Bernstein I D, Hansen J A 1987. "Human large granular lymphocytes express high affinity receptors for murine monoclonal antibodies of the IgG3 subclass." Journal of immunology (Baltimore, Md. : 1950) 138 (9) doi:

1986

Anasetti C, Doney K C, Storb R, Meyers J D, Farewell V T, et al. 1986. "Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients." Annals of internal medicine 104 (4) doi:

1985

Landreth K S, Engelhard D, Anasetti C, Kapoor N, Kincade P W, Good R A 1985. "Pre-B cells in agammaglobulinemia: evidence for disease heterogeneity among affected boys." Journal of clinical immunology 5 (2) doi:

1983

Liberati A M, Di Costanzo F, Anasetti C, Buzzi F, Falchi R, Grignani F 1983. "Humoral nonparathyroid hypercalcemia without evidence of bone involvement." Tumori 69 (3) doi: